Pharmicell Co., Ltd. (005690.KS) KSC
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 872.05B |
| Enterprise Value | 857.78B |
| P/E Ratio | 13.96 |
| PEG Ratio | 0.08 |
| Price/Sales Ratio | 4.91 |
| Price/Book Ratio | 4.58 |
| Enterprise/Revenue | 4.89 |
| Enterprise/EBITDA | 14.4 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.35 |
| Operating Margin | 0.32 |
AD
Management Effectiveness
| Return On Assets | 0.26 |
| Return On Equity | 0.37 |
Income Statement
| Revenue | 114.06B |
| Revenue/Share | 2,061.92 |
| Gross Profit | 50.01B |
| EBITDA | 36.81B |
| Net Income | 40.33B |
| Diluted EPS | 671.97 |
Balance Sheet
| Total Cash | 60.1B |
| Total Cash/Share | 1,001.52 |
| Total Debt | 20.51B |
| Total Debt/Equity | 0.15 |
| Current Ratio | 6.86 |
| Book Value Per Share | 2,212.91 |
Price History
| 52-Week Change | -17.78 |
| 52-Week High | 21,150 |
| 52-Week Low | 8,140 |
| Moving Average 50 Days | 12,813.2 |
| Moving Average 200 Days | 15,290.25 |
Statistics
| Average Volume | 780,006 |
| Shares Outstanding | 60M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 50 |
| Trailing Annual Dividend Yield | 0.49 |
| Payout Ratio | 0.03 |
| Last Split Factor | 531:500 |
| Last Split Date | April 30, 2012 |
AD
